ArticleEuropean radiology2024

Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [

R Ebner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.